Screener
Stoke Therapeutics, Inc. STOK Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses | 10,115 | 8,736 |
| Interest receivable | 1,690 | 1,969 |
| Other current assets | 6,880 | 4,389 |
| Total current assets | $366,681 | $305,700 |
| Marketable securities - long-term | 67,481 | 106,260 |
| Restricted cash - long-term | 3,227 | 227 |
| Operating lease right-of-use assets | 2,493 | 3,101 |
| Property and equipment, net | 3,395 | 3,146 |
Item 1. Financial Statements.
FAQ
- What is Stoke Therapeutics, Inc.'s total current assets?
- Stoke Therapeutics, Inc. (STOK) reported total current assets of $366.68M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s total current assets changed year-over-year?
- Stoke Therapeutics, Inc.'s total current assets decreased by 2.4% year-over-year, from $375.74M to $366.68M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s total current assets has grown at a 0.8% compound annual growth rate (CAGR), from $293.93M to $305.7M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Stoke Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude